Morbid Characteristics | n(%) |
---|---|
Type of brain tumor | |
 Glioma | 78 (24.68%) |
 WHO I-II | 14 (4.43%) |
 WHO III-IV | 64 (20.25%) |
 Meningioma | 3 (9.49%) |
 Lymphoma | 5 (1.58%) |
Brain Metastases | |
 From lung cancer | 102 (32.27%) |
 From breast cancer | 113 (35.75%) |
 From other cancer | 15 (4.73%) |
Treatment currently receiving | |
 Surgery | 26 (8.22%) |
 Radiotherapy | 233 (73.74%) |
 Medicine | 46 (14.55%) |
 Support treatment | 11 (3.49%) |
Duration of illness | |
 1 month or less | 81 (25.63%) |
 2 months to 6 months | 32 (10.13%) |
 7 months to 12 months | 54 (17.08%) |
 12 months to 24 months | 90 (28.48%) |
 25 months or more | 59 (18.68%) |
Symptoms | |
 Headache | 181 (57.27%) |
 epilepsy | 21 (6.65%) |
 Movement disorders | 78 (24.69%) |
 Language disorders | 36 (11.39%) |
KPS scores | |
 <50 | 37 (11.71%) |
 60–79 | 196 (62.02%) |
 >80 | 83 (26.27%) |